- US-listed companies
- Aligos Therapeutics, Inc.
- Financials
- Cash from investing
Aligos Therapeutics, Inc. (ALGS)
Market cap
$5.34M
P/E ratio
| Period End | Cash from investing (Million USD) | YoY (%) |
|---|---|---|
| Dec 31, 2024 | -18 | -140.64% |
| Dec 31, 2023 | 45 | -271.08% |
| Dec 31, 2022 | -26 | -970.05% |
| Dec 31, 2021 | 3 | -90.77% |
| Dec 31, 2020 | 33 |